magnifying glass
logo for Visterra

Visterra

Get Full Access

Description

Founded in 2007 and headquartered in Waltham, Massachusetts, Visterra is a clinical-stage biotechnology company that creates antibody-based therapies for the tr... Read More

Headquarters

Headquarters:

275 2nd Ave, Waltham, Massachusetts, 02451, United States
Phone

Phone:

(617) 498-1070
Employees

Employees:

99
Revenue

Revenue:

$19 Million
Visterra's Social Media
SIC Code 2833,87
NAICS Code 541713,325411
Popular Searches:

Visterra

visterra , inc.

Visterra Inc

Visterra Inc.

VISTERRA, INC.

Top Competitors of Visterra

Employess
34
revenue
$6 Million

1

Employess
69
revenue
$14 Million

2

Employess
32
revenue
$6 Million

3

Employess
<25
revenue
<$5 Million

4

Employess
44
revenue
$8 Million

5

Employess
90
revenue
$30 Million

6

Visterra's Org Chart

Brian Pereira
Brian Pereira

President & Chief Executive Officer

PhonePhoneEmailEmail
Peter Courossi
Peter Courossi

Chief Financial Officer

PhonePhoneEmailEmail
David Oldach
David Oldach

Chief Medical Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Visterra Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateRoundAmountInvestors

Oct 04, 2017

Series C

$23M

Allegheny Financial Group

Oct 01, 2014

Series B

$30M

Temasek

Nov 09, 2012

Series A

$26M

Lux Capital

See More

$115M

Total Funding Amount

$23M

Most Recent Funding Amount

5

Number of Funding Rounds

Revenue
QuarterRevenue

'20 - Q3

10000000

'20 - Q4

10000000

'21 - Q1

19787000

'21 - Q2

19787000

Acquisitions & Subsidiaries

Feb 19, 2016

Uqora

Apr 28, 2012

Visterra

Soyjoy

Avanir Pharmaceuticals

Pharmavite

Astex Pharmaceuticals

See More Acquisitions & Subsidiaries

Visterra's Tech Stack

Google Analytics

By

Google

Google Global Site Tag

By

Google

Microsoft PowerPoint

By

Microsoft

Microsoft Project

By

Microsoft

Google Maps API

By

Google

Office 365

By

Microsoft
See more technologies

Visterra News & Media

Visterra Presents Data Demonstrating Safety, Tolerability and Positive Clinical Activity Trends of VIS410 in Non-Hospitalized Patients with Influenza A

WALTHAM, Mass.--(BUSINESS WIRE)--Visterra VIS410 data shows reductions in time to resolution of viral load in patients and in vitro antiviral activity in combo with antivirals

Visterra Initiates Phase 1 Clinical Study of VIS649

WALTHAM, Mass.--(BUSINESS WIRE)--Visterra Initiates Phase 1 Clinical Study of VIS649, its Novel Monoclonal Antibody for the Treatment of IgA Nephropathy.

Otsuka completes Visterra acquisition for about $430 mln

Otsuka has closed its previously announced acquisition of Visterra, a developer of antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases, for about $430 million in cash. Visterra's backers included Polaris Partners, Flagship Pioneering, the Bill and Melinda Gates Foundation, MRL Ventures Fund, Vertex Ventures HC, Temasek Holdings, Lux Capital, Alleghany Financial Group Ventures, CTI Life Sciences Fund and Alexandria Equities.
Subscribe to "Visterra" News

Frequently Asked Questions regarding Visterra

Where are Visterra’s headquarters?

Visterra’s headquarters are in 275 2nd Ave, Waltham, Massachusetts, 02451, United States

What is Visterra’s phone number?

Visterra’s phone number is (617) 498-1070

What is Visterra’s official website?

Visterra’s official website is //www.visterrainc.com

What is Visterra’s Revenue?

Visterra’s revenue is $19 Million

What is Visterra’s SIC code?

Visterra’s SIC: 2833,87

What is Visterra’s NAICS code?

Visterra’s NAICS: 541713,325411

How many employees are working in Visterra?

Visterra has 99 employees

What is Visterra’s industry?

Visterra is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

Who are Visterra’s main competitors?

Visterra's main competitors are: Biokine Therapeutics, Magenta Therapeutics, Step Pharma, Leap Therapeutics

What companies has Visterra acquired?

Visterra has acquired the companies: Uqora, Visterra, Soyjoy, Avanir Pharmaceuticals

What is Visterra's tech stack?

The technologies that are used by Visterra are: Google Analytics, Google Global Site Tag, Microsoft PowerPoint, Microsoft Project

Who is Visterra's CEO?

Visterra's CEO is Brian Pereira

Who is Visterra's CFO?

Visterra's CFO is Peter Courossi

See more information about Visterra

Browse ZoomInfo’s Directories